Pancreatic Cancer Research

ResearcherIncyte CorporationNo recent work listed

Peter B. Langmuir

Known by name at one institution; no external author ID yet. Name as it appears in ClinicalTrials.gov.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
0
Pancreatic cancer trials
2
Pancreatic cancer grants
0
Collaborators
0
Papers, trials and grants by year

2016: 2 trials

Trials 2

  1. Pembrolizumab Combined With Itacitinib (INCB039110) and/or Pembrolizumab Combined With INCB050465 in Advanced Solid Tumors Study director NCT02646748↗
  2. An Open-Label Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib Study director NCT02955940↗

Closest collaborators

No collaborators recorded.

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.